Mellitus is developing a novel in vitro diagnostic test for the measurement of Glycated CD59 (GCD59) with potential clinical utility in screening, diagnosis and monitoring of diabetes, stratification of complications risk and as a clinical trial test for pharmaceutical development. Mellitus' lead product candidate is a test for Gestational Diabetes Mellitus (GDM).

Medical Devices

Mellitus

Mellitus' headquarters in Boston, MA, United States

Rick Saul

Kathy Welch

Jing Shi

Christopher De Souza

Jose A. Halperin

Thomas J. Musci

Michael Chorev

Ellie McGuire

Description

People (2)

Christopher De Souza

Jing Shi

Jobs